In this study, we demonstrated the ability of shikonin to induce necroptosis both in TKI-sensitive CML cell lines and in TKI-resistant CML cells bearing the T315I mutation in the Bcr/Abl gene. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.